HPV vaccination strategy for 14-year-old females and economic returns for cervical cancer prevention in Wuxi City, China: a cost effectiveness analysis-Reference-Cited by-同舟云学术

HPV vaccination strategy for 14-year-old females and economic returns for cervical cancer prevention in Wuxi City, China: a cost effectiveness analysis

Published:2024-09-05 Issue:1 Volume:22 Page:
ISSN:1478-7547
Container-title:Cost Effectiveness and Resource Allocation
language:en
Short-container-title:Cost Eff Resour Alloc

Author:

Jiang Jingfeng,Zhao Fanqi,Hong Xiang,Wang Xuwen

Funder

Wuxi Development Discipline Construction Project

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1186/s12962-024-00574-9.pdf

Reference40 articles.

1. Di J, Rutherford S, Chu C. Review of the Cervical Cancer Burden and Population-Based Cervical Cancer Screening in China. Asian Pac J Cancer Prev. 2015;16(17):7401-7. https://doi.org/10.7314/apjcp.2015.16.17.7401. PMID: 26625735.

2. Guo M, Xu J, Du J. Trends in cervical cancer mortality in China from 1989 to 2018: an age-period-cohort study and joinpoint analysis. BMC Public Health. 2021;21(1):1329. https://doi.org/10.1186/s12889-021-11401-8. PMID: 34229639; PMCID: PMC8259057.

3. Bray Freddie F, Jacques S, Isabelle, et al. Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.[J]. CA Cancer J Clin. 2018;68:394–424.

4. Zhu X, Wang Y, Lv Z, Su J. Prevalence and genotype distribution of high-risk HPV infection among women in Beijing, China. J Med Virol. 2021;93(8):5103–5109. https://doi.org/10.1002/jmv.27013. Epub 2021 May 3. PMID: 33847386.

5. Sabatini ME, Chiocca S. Human papillomavirus as a driver of head and neck cancers. Br J Cancer. 2020;122(3):306–14. https://doi.org/10.1038/s41416-019-0602-7. Epub 2019 Nov 11. PMID: 31708575; PMCID: PMC7000688.